Abcam Ltd - Company Profile
Powered by 
All the sales intelligence you need on Abcam Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Abcam Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Abcam Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Abcam Ltd (Abcam) a subsidiary of Danaher Corp, is a biotechnology company that focuses on the research, development, marketing and sales of research-grade antibodies and related products. Its product portfolio comprises antibody reagents, antigens, and test kits. Strategic partnerships, focus on research and development activities, and proprietary RabMab technology are its strengths, while private ownership could be an area of concern for the company. Abcam could benefit from the market potential for Alzheimer's disease, strategic agreement, and positive outlook of the diagnostic imaging market. However, its performance could be affected by stiff competition, introduction of innovative technologies, and stringent government regulations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer